Efficacy and Safety of CVT-E002, a Proprietary Extract of <i>Panax quinquefolius</i> in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial

<table>Disposition of the participants in the trial.</table>

Influenza Research and Treatment

fig1

Figure 1

Figure 1: Efficacy and Safety of CVT-E002, a Proprietary Extract of <i>Panax quinquefolius</i> in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial 

Figure 1 | Efficacy and Safety of CVT-E002, a Proprietary Extract of Panax quinquefolius in the Prevention of Respiratory Infections in Influenza-Vaccinated Community-Dwelling Adults: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial 